Hyperion Defi (HYPD) EBIT Growth (5y) (2022 - 2026)
Hyperion Defi (HYPD) EBIT Growth (5y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.40 Bn | 131.55 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.53 Bn | 78.54 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.20 Bn | 60.02 Bn | 1.37 Bn |
| 4 | Moderna | 60.40 Bn | 55.26 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.17 Bn | 37.07 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.36 Bn | 28.05 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.74 Bn | 10.34 Bn | 668.28 Mn |
| 8 | Insmed | 27.45 Bn | 26.29 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.17 Bn | 26.33 Bn | - |
| 10 | Hyperion Defi | 46.91 Mn | 37.28 Mn | 357,693.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 53.36% |
| Mar 31, 2026 | 29.39% |
| Dec 31, 2025 | -56.72% |
| Sep 30, 2025 | 23.47% |
| Jun 30, 2025 | -10.72% |
| Mar 31, 2025 | 11.14% |
| Dec 31, 2024 | -29.75% |
| Sep 30, 2024 | -9.34% |
| Jun 30, 2024 | -16.80% |
| Mar 31, 2024 | -11.52% |
| Dec 31, 2023 | -3.84% |
| Sep 30, 2023 | -8.58% |
| Jun 30, 2023 | -12.41% |
| Mar 31, 2023 | -9.73% |
| Dec 31, 2022 | -19.95% |
| Sep 30, 2022 | -52.20% |
| Jun 30, 2022 | -48.78% |
| Mar 31, 2022 | -45.38% |